Search

Displaying results 9101 - 9110 of 10000 in total
  1. Drug

    Stibophen

    go.drugbank.com/drugs/DB13236
    Experimental

    Stibophen is used in the treatment of schistosomiasis, a disease of parasitic flatworms.

  2. Drug

    INO-4995

    go.drugbank.com/drugs/DB17834
    Experimental

    INO-4995 is an inositol tetrakisphosphate analog being investigated for Cystic Fibrosis.[A259781]

  3. Drug

    Novolimus

    go.drugbank.com/drugs/DB19085
    Investigational

    Novolimus is under investigation in clinical trial NCT04483791 (Dynamx Bioadaptor Hong Kong Registry).

  4. Drug

    Lixudebart

    go.drugbank.com/drugs/DB19244
    Investigational

    Lixudebart, an investigational first-in-class monoclonal antibody, aims to reverse fibrosis.[L50833]

  5. Drug

    NP-6A4

    go.drugbank.com/drugs/DB17599
    Experimental

    NP-6A4 is a peptide designed to specifically bind and activate angiotensin II receptor type 2 (AT2R). It has an Orphan Drug designation from the FDA for pediatric cardiomyopathy.[A258523]

  6. Drug

    AZD8630

    go.drugbank.com/drugs/DB19397
    Investigational

    AZD8630 is an experimental drug under investigation, as described in the Phase I clinical study titled "Randomised, Blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics

  7. Drug

    Martinostat

    go.drugbank.com/drugs/DB14979
    Investigational

    Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast Cancer).

  8. Drug

    Fibronectin

    go.drugbank.com/drugs/DB15150
    Investigational

    Fibronectin is under investigation in clinical trial NCT01812239 (Vaginal Progesterone in Twins With Short Cervix).

  9. Drug

    Nerinetide

    go.drugbank.com/drugs/DB12595
    Investigational

    Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).

  10. Drug

    Bifikafusp alfa

    go.drugbank.com/drugs/DB19185
    Investigational

    Bifikafusp alfa is under investigation in clinical trial NCT05329792 (L19IL2/L19TNF in Skin Cancer Patients).